Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals
Mahmoud, H., Zakaria, S., Kishk, R., Al-Amir, A. (2021). Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals. EKB Journal Management System, 2(2), 308-316. doi: 10.21608/mid.2021.53173.1096
Hasnaa Mahmoud; Sahar Zakaria; Rania Kishk; Amro Al-Amir. "Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals". EKB Journal Management System, 2, 2, 2021, 308-316. doi: 10.21608/mid.2021.53173.1096
Mahmoud, H., Zakaria, S., Kishk, R., Al-Amir, A. (2021). 'Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals', EKB Journal Management System, 2(2), pp. 308-316. doi: 10.21608/mid.2021.53173.1096
Mahmoud, H., Zakaria, S., Kishk, R., Al-Amir, A. Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals. EKB Journal Management System, 2021; 2(2): 308-316. doi: 10.21608/mid.2021.53173.1096

Effect of Meropenem-Colistin and Meropenem-Amikacin Combinations against Carbapenem-Resistant Pseudomonas aeruginosa Isolates in Suez Canal University Hospitals

Microbes and Infectious Diseases
Article 16, Volume 2, Issue 2, May 2021, Page 308-316  XML PDF (299.77 K)
Document Type: Original Article
DOI: 10.21608/mid.2021.53173.1096
View on SCiNiTO View on SCiNiTO
Authors
Hasnaa Mahmoud1; Sahar Zakaria1; Rania Kishk email 2; Amro Al-Amir1
1Microbiology And Immunology Department, Faculty Of Medicine, Suez Canal University Round Road 4.5km
2Medical microbiology and immunology faculty of medicine Suez Canal University, Egypt
Abstract
Background: Healthcare associated infections (HAIs) caused by carbapenem-resistant P. aeruginosa are considered as an overwhelming problem in hospitals due to its resistance to most effective antibiotic classes. Consequently, various antimicrobial combinations have been suggested as an alternative in clinical practice. So, our aim was to improve the antibiotic policy in Suez Canal University Hospitals (SCUHs) in the treatment of carbapenem-resistant Pseudomonas aeruginosa infections and to reduce morbidity and mortality rates due to these infections.
Materials and methods: A cross-sectional descriptive study was carried out on 36 Carbapenem-resistant Pseudomonas aeruginosa strains collected from different wards in SCUHs. A checkerboard assay was carried on these strains to assess the effect of meropenem colistin and meropenem-amikacin combination.
Results: the synergy testing of the meropenem-amikacin combination on Carbapenem-resistant Pseudomonas aeruginosa showed 50% synergy, 8.3% addition, 36% indifference and 5.7% antagonism. For the meropenem-colistin combination, it showed 39% synergism, 30.5% addition and 30.5% indifference with no antagonism was observed. Although, the mean FIC value of meropenem was higher in the meropenem-amikacin combination than in the meropenem-colistin combination, the difference was statistically insignificant.
Conclusions: Both combinations (meropenem colistin and meropenem-amikacin) showed high rates of synergy and reduction of meropenem MICs against Carbapenem-Resistant Pseudomonas aeruginosa Isolates and can offer good alternatives in the clinical practice for treatment of CRPA strains.
Keywords
P.aeruginosa; colistin; Amikacin; Meropenem; checkerboard technique.  
Statistics
Article View: 892
PDF Download: 524